Inclisiran for LDL-C reduction in secondary prevention: Real-world evidence from a homogeneous Spanish cohort with subgroup insights.

Leqvio (inclisiran) - Novartis

Nexletol (bempedoic acid) - Esperion Therap, CSL Behring

ezetimibe - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42248700

Antonio García; Elena Fuente; Francisco Romano; María Del Val Groba; Mario Galván; Marta López; Miguel Fernandez; Victoria Piro

Jun 6, 2026